Type-1 Diabetes Treatment Market Analysis
The global type 1 diabetes treatment market is predicted to touch USD 9.6 billion at a 7.9% CAGR between 2019- 2025, as per the recent Market Research Future (MRFR) analysis. Type 1 diabetes or diabetes mellitus or juvenile diabetes is a multifactorial autoimmune and chronic condition when the body produces no or little insulin in the pancreas. The insulin hormone is required by the body for getting glucose into the cells from the bloodstream for producing energy. Long-acting insulin, medium-acting insulin, short-acting insulin, rapid-acting insulin, and others are the different types of type 1 diabetes treatment that is widely used in specialty centres, hospitals and clinics, and others.
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/8199
Various factors are propelling the global type 1 diabetes treatment growth. According to the latest MRFR report, such factors include support from the government for type 1 diabetes treatment, improved diagnostic capabilities guaranteeing early detection, increasing access to medication across the globe, increasing spending on healthcare worldwide, rising prevalence of obesity, growing geriatric population, and growing prevalence of type-1 diabetes owing to genetic and environmental factors.
On the contrary, strict approval process which differs from one nation to another, the grave effect of the COVID-19 outbreak, and the medications’ negative side effects are factors that may impede the global type 1 diabetes treatment market growth over the forecast period.
Type-1 Diabetes Treatment Market Segmentation
The MRFR report provides an inclusive segmental analysis of the global type 1 diabetes treatment market based on end user and product.
By end user, the global type 1 diabetes treatment market is segmented into specialty centres, hospitals and clinics, and others. The others have been segmented into treatment at old age homes and home. Among these, hospitals and clinics will have lions share over the forecast period.
By product, the global type 1 diabetes treatment market is segmented into long-acting insulin, medium-acting insulin, short-acting insulin, rapid-acting insulin, and others. The others have been segmented into inhaled insulin and ultra long-term action insulin. Of these, the rapid-acting insulin will dominate the market over the forecast period. It is further segmented into Novolog, Humalog, and Admelog.
Type-1 Diabetes Treatment Market Regional Analysis
Based on the region, the global type 1 diabetes treatment market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific (APAC), & the Middle East and Africa (MEA). Of these, North America will have lions share in the market over the forecast period. Immense growth possibilities, growing awareness amid people, improved investment opportunities, rising investment in research and technology, accessibility of pharmaceutical support, improved technological support, and companies taking an interest in the market are adding to the global type 1 diabetes market treatment market growth in the region.
The global type 1 diabetes treatment market in Europe is predicted to hold the second-largest share over the forecast period. Favorable initiatives undertaken by investors and research institutes that are all set to contribute to the R&D sector is adding to the global type 1 diabetes treatment market growth in the region.
The type 1 diabetes treatment market in the APAC region is predicted to grow at a fast pace over the forecast period. Massive population, developing healthcare sector, and growing awareness about the diseases are adding to the type 1 diabetes treatment market growth in the region.
The global type 1 diabetes treatment market in the MEA is predicted to have sound growth over the forecast period.
Type-1 Diabetes Treatment Market Key Players
Key players profiled in the global type 1 diabetes treatment market report include Biodel, Inc. (US), DiaVacs, Inc. (US), Macrogenics, Inc. (US), Braun Melsungen AG (Germany), Mannkind Corporation (US), Abbott Laboratories (US), Pfizer Inc. (US), Novartis (Switzerland), Boehringer Ingelheim GmbH (Germany), AstraZeneca (UK), Sanofi (France), Novo Nordisk (Denmark), Merck (US), Eli Lilly (US), and Astellas Pharma (Japan).
Table Of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
Chapter 5. Market Factor Analysis
…TOC Continued
LIST OF TABLES
Table 1 Global Type-1 Diabetes Treatment Synopsis, 2019–2025
Table 2 Global Type-1 Diabetes Treatment Market Estimates & Forecast, 2019–2025 (USD Million)
Table 3 Global Type-1 Diabetes Treatment Market, By Region 2019–2025 (USD Million)
Table 4 Global Type-1 Diabetes Treatment Market, By Product 2019–2025 (USD Million)
Table 5 Global Type-1 Diabetes Treatment Market, By End User 2019–2025 (USD Million)
Table 6 Americas: Type-1 Diabetes Treatment Market, By Product 2019–2025 (USD Million)
…Continued
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation Of The Global Type-1 Diabetes Treatment Market
Figure 3 Market Dynamics For The Global Type-1 Diabetes Treatment Market
Figure 4 Global Type-1 Diabetes Treatment Market Share, By Product, 2018
Figure 5 Global Type-1 Diabetes Treatment Market Share, By End User, 2018
Figure 6 Global Type-1 Diabetes Treatment Market Share, By Region, 2018
…Continued
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/type-1-diabetes-treatment-market-8199
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: www.marketresearchfuture.com/reports/type-1-diabetes-treatment-market-8199